ENB Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2015-05-04
- Employees
- 1
- Market Cap
- -
- Website
- http://www.enbpharma.com
Clinical Trials
1
Active:1
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors
Phase 1
Active, not recruiting
- Conditions
- MelanomaOvary CancerCancerPancreatic CancerSolid Tumor
- Interventions
- First Posted Date
- 2019-12-19
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- ENB Therapeutics, Inc
- Target Recruit Count
- 137
- Registration Number
- NCT04205227
- Locations
- 🇺🇸
Cedars Sinai-The Angeles Clinic, Los Angeles, California, United States
🇺🇸MD Anderson Cancer Center, Houston, Texas, United States
🇦🇺Border Medical Oncology, Albury, New South Wales, Australia
News
No news found